Clinical trials: Malaria Vaccines
Malaria, Malaria Vaccines
Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccine
Background: Malaria, a disease transmitted by mosquitoes, affects millions of people with the highest frequency, morbidity, and mortality in infants and young children.
- Conditions
- Malaria, Malaria Vaccines, Plasmodium Falciparum Malaria
- Trial name
- NCT00977899
- Testing
- Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Plasmodium Falciparum Malaria, Vaccines
Experimental Vaccine for Plasmodium Falciparum Malaria
This study will evaluate the safety of two experimental malaria vaccines in healthy volunteers and examine their immune response to them.
- Trial name
- NCT00340431
- Testing
- MSP1(42)-FVO & MSP1(42)-3D7
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)